> ## Content Index
> Fetch the complete content index at: https://www.neurabc.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# World's First Tinnitus BCI Accelerates China Deployment: Swiss Neurosoft Establishes Foothold in Fujian
- URL: https://www.neurabc.com/worlds-first-tinnitus-bci-accelerates-china-deployment-swiss-neurosoft-establishes-foothold-in-fujian/
- Published: 2026-11-12T08:25:45.000Z
- Updated: 2026-11-12T08:25:45.000Z
- Author: zhangguanghua

Recently, Swiss brain-computer interface company Neurosoft Bioelectronics won the gold prize in the Biotechnology track of the Fujian Global Innovation and Entrepreneurship Competition and was named "Fujian's Iconic BCI Product." The significance of this goes beyond a mere award; it serves as a signal that China's local industrial ecosystem is actively embracing cutting-edge international BCI technology, and Neurosoft is using this to advance the China deployment of its high-bandwidth flexible interface.

Neurosoft's core technology is called SOFT ECoG, an ultra-flexible interface that adheres to the brain cortex surface without penetrating brain tissue. Its material is 1,000 to 100,000 times softer than the rigid electrodes used in traditional craniotomy surgeries, allowing it to conform to the folds of the brain's gyri. Its coverage area is approximately 30 times that of conventional electrodes. During the subacute phase, it can operate continuously for 30 days while performing high-density signal recording and stimulation simultaneously. This material is not a single product but a technology platform that can spawn various BCI products for treating tinnitus, epilepsy, motor restoration, and more.

![](https://storage.ghost.io/c/d7/ad/d7ad0812-3a09-4fff-8aca-bda39840d264/content/images/2026/11/export_bg_neurofeedbackloop_10.jpg)

The first indication being targeted is tinnitus. Approximately 14% of the global population suffers from tinnitus, with about 120 million people experiencing severe cases, often accompanied by long-term anxiety, insomnia, depression, and even suicidal tendencies. Existing treatments mostly only alleviate symptoms without providing a cure. SOFT TINNIT, currently under development by Neurosoft, is the world's first fully implantable closed-loop BCI designed for severe tinnitus. 

Unlike hearing aids that amplify sound or maskers that cover tinnitus with noise, it reads abnormal brain activity related to tinnitus and performs neuromodulation on specific brain regions to weaken tinnitus perception at the mechanistic level. In early studies, the average score on a professional tinnitus assessment scale dropped by 28 points, with an improvement rate approximately 2.3 times that of traditional psychological counseling therapies. The company has completed around 10 human implants to date, conducted in two clinical trials in Houston and Utrecht.

Platformization is Neurosoft's true ambition. The same soft electrode can spawn the MINDZ product for minimally invasive burr-hole implantation and localization of drug-resistant epilepsy foci; and Synapsuit, which works with soft exoskeletons to restore upper limb function in paralyzed patients. Additionally, the company collects large-scale cortical data for motor intention decoding. CEO Nicolas Vachicouras calls this dataset the fuel for a cortical foundation model, which in the future may serve not only medical devices but also feed back into humanoid robots' understanding of high-precision motor control.

![](https://storage.ghost.io/c/d7/ad/d7ad0812-3a09-4fff-8aca-bda39840d264/content/images/2026/11/Neurofeedback_fMRI_2a.png)

The choice of Fujian for China deployment is logically clear. BCI has been included in the future industry direction of the national 15th Five-Year Plan (2026–2030), and Fujian has launched a BCI industry development action plan for 2026 to 2030\. The Xiamen Pilot Free Trade Zone has introduced 391 institutional innovations, 74 of which are national firsts, including China's first bonded maintenance pilot for third-party medical devices, providing regulatory flexibility and industrial chain support for emerging technologies. 

Neurosoft is deeply tied to the Neurotechnology Innovation and Impact Institute (N3I) of West China Hospital of Sichuan University in Xiamen, with BCI expert Professor Gerwin Schalk providing core technical support. The institute operates in both Xiamen and Chengdu, undertaking the full chain of functions from scientific research validation, clinical translation to commercial incubation. SOFT ECoG is moving from the prototype stage to industrialization, with the next step planned to advance clinical validation of 30-day monitoring for drug-resistant epilepsy in Xiamen.

Horizontally, there is currently no implantable BCI specifically for tinnitus on the market in China. Wuhan, Beijing, and other places are advancing non-invasive closed-loop solutions that rely on scalp EEG decoding combined with individualized acoustic and electrical stimulation, which are more accessible to mild and moderate patients but have a resolution ceiling for extremely severe cases and deep brain regions. Neurosoft takes the high-bandwidth intracranial route, which has a higher ceiling but a longer validation cycle. The two paths are not substitutes but complementary layers based on disease severity and payment ability.

![](https://storage.ghost.io/c/d7/ad/d7ad0812-3a09-4fff-8aca-bda39840d264/content/images/2026/11/Screenshot-2026-10-19-at-16.23.11.png)

Returning to the industry coordinates: In March this year, domestic company Neuracle's NEO product obtained the world's first Class III medical device registration certificate for an invasive BCI, meaning that BCI has achieved clinical prescription, commercial implantation, and entered the medical insurance coding stage for the first time. In the same period, the semi-annual investment scale of China's BCI sector approached US$1 billion. Neurosoft is catching the window of China's transition from laboratory verification to clinical scaling. What it brings is not a single-point device but a complete set of interface infrastructure that can be mass-produced and collect high-quality cortical data.

![](https://storage.ghost.io/c/d7/ad/d7ad0812-3a09-4fff-8aca-bda39840d264/content/images/2026/11/pack_bg_3b.jpg)

From reading brains and controlling cursors to hearing silence and rebuilding movement, BCI is leaving the stage of demonstrating miracles and entering the deep water of system-level clinical and industrial application. This gold prize in Fujian is a new coordinate on this track that deserves continuous tracking.